The heart, kidney, and brain as target organs in hypertension - PubMed (original) (raw)
Review
The heart, kidney, and brain as target organs in hypertension
George A Mensah et al. Cardiol Clin. 2002 May.
Abstract
The heart, kidney, brain, and arterial blood vessels are prime targets of hypertensive damage. Uncontrolled hypertension accelerates the damage to these organs and results in eventual organ failure and cardiovascular death and disability. Current guidelines for the appropriate treatment and control of hypertension requires an assessment of the presence of target organ damage. When present, evidence of target organ damage determines the urgency and intensity of drug treatment and may also dictate the choice of initial antihypertensive drug class. Thus, evaluation of persons with suspected or established hypertension must include a meticulous search for evidence of target organ damage. Fortunately, treatment with all antihypertensive medications that results in significant BP reductions also reduces fatal and nonfatal hypertensive complications and significantly slows down the progression to organ failure. Because of the important role that adverse activation of the renin-angiotensin-aldosterone system plays in target organ damage, drugs that antagonize this system have provided consistent and compelling proof of organ protection in both primary and secondary prevention of adverse outcomes. The challenge now is to use these and all other antihypertensive agents effectively to control BP to target levels in patients with hypertension. Continued emphasis on the adoption of lifestyle changes for prevention of hypertension in the first place or as adjunctive therapy in hypertensive patients is essential.
Similar articles
- Recent insights in the development of organ damage caused by hypertension.
Persu A, De Plaen JF. Persu A, et al. Acta Cardiol. 2004 Aug;59(4):369-81. doi: 10.2143/AC.59.4.2005202. Acta Cardiol. 2004. PMID: 15368798 Review. - Mechanisms of target organ damage caused by hypertension: therapeutic potential.
Cohuet G, Struijker-Boudier H. Cohuet G, et al. Pharmacol Ther. 2006 Jul;111(1):81-98. doi: 10.1016/j.pharmthera.2005.09.002. Epub 2005 Nov 8. Pharmacol Ther. 2006. PMID: 16288809 Review. - Blood pressure biofeedback treatment, organ damage and sympathetic activity in mild hypertension.
Nakao M, Nomura S, Shimosawa T, Fujita T, Kuboki T. Nakao M, et al. Psychother Psychosom. 1999;68(6):341-7. doi: 10.1159/000012353. Psychother Psychosom. 1999. PMID: 10559715 Clinical Trial. - Hypertensive Mediated Organ Damage and Hypertension Management. How to Assess Beneficial Effects of Antihypertensive Treatments?
Piskorz D. Piskorz D. High Blood Press Cardiovasc Prev. 2020 Feb;27(1):9-17. doi: 10.1007/s40292-020-00361-6. Epub 2020 Jan 23. High Blood Press Cardiovasc Prev. 2020. PMID: 31975151 Review. - Target organ damage and associated clinical conditions among Nigerians with treated hypertension.
Ayodele OE, Alebiosu CO, Salako BL, Awoden OG, Abigun AD. Ayodele OE, et al. Cardiovasc J S Afr. 2005 Mar-Apr;16(2):89-93. Cardiovasc J S Afr. 2005. PMID: 15915275
Cited by
- Association of the low e' and high E/e' with long-term outcomes in patients with normal ejection fraction: a hospital population-based observational cohort study.
Seko Y, Kato T, Shiba M, Morita Y, Yamaji Y, Haruna Y, Nakane E, Hayashi H, Haruna T, Inoko M. Seko Y, et al. BMJ Open. 2019 Nov 21;9(11):e032663. doi: 10.1136/bmjopen-2019-032663. BMJ Open. 2019. PMID: 31753896 Free PMC article. - Molecular Interactions of Arterial Hypertension in Its Target Organs.
Kućmierz J, Frąk W, Młynarska E, Franczyk B, Rysz J. Kućmierz J, et al. Int J Mol Sci. 2021 Sep 7;22(18):9669. doi: 10.3390/ijms22189669. Int J Mol Sci. 2021. PMID: 34575833 Free PMC article. Review. - Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.
Jin L, Piao ZH, Sun S, Liu B, Kim GR, Seok YM, Lin MQ, Ryu Y, Choi SY, Kee HJ, Jeong MH. Jin L, et al. Sci Rep. 2017 Nov 15;7(1):15607. doi: 10.1038/s41598-017-15925-1. Sci Rep. 2017. PMID: 29142252 Free PMC article. - The Increasing Problem of Resistant Hypertension: We'll Manage till Help Comes!
Natale F, Franzese R, Luisi E, Mollo N, Marotta L, Solimene A, D'Elia S, Golino P, Cimmino G. Natale F, et al. Med Sci (Basel). 2024 Oct 4;12(4):53. doi: 10.3390/medsci12040053. Med Sci (Basel). 2024. PMID: 39449409 Free PMC article. Review. - The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.
Capdevila JH, Pidkovka N, Mei S, Gong Y, Falck JR, Imig JD, Harris RC, Wang W. Capdevila JH, et al. J Biol Chem. 2014 Feb 14;289(7):4377-86. doi: 10.1074/jbc.M113.508416. Epub 2013 Dec 24. J Biol Chem. 2014. PMID: 24368771 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical